Aemetis (NASDAQ:AMTX) Posts Quarterly Earnings Results, Beats Estimates By $0.41 EPS

Aemetis (NASDAQ:AMTXGet Rating) announced its earnings results on Thursday. The specialty chemicals company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.44) by $0.41, Fidelity Earnings reports. During the same quarter in the prior year, the firm earned ($0.38) EPS.

Aemetis Stock Up 24.8 %

Shares of AMTX opened at $10.18 on Friday. Aemetis has a 12-month low of $4.45 and a 12-month high of $23.33. The business has a 50-day simple moving average of $6.33 and a two-hundred day simple moving average of $9.05. The stock has a market cap of $352.02 million, a PE ratio of -9.01 and a beta of 0.62.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Credit Suisse Group dropped their price objective on Aemetis from $35.00 to $27.00 and set an “outperform” rating for the company in a research report on Monday, June 13th. Ascendiant Capital Markets downgraded Aemetis to an “outperform” rating and set a $33.00 price objective for the company. in a research report on Monday, June 6th. One investment analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $31.00.

Hedge Funds Weigh In On Aemetis

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Charles Schwab Investment Management Inc. increased its holdings in Aemetis by 3.1% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 75,306 shares of the specialty chemicals company’s stock worth $955,000 after purchasing an additional 2,254 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Aemetis by 16.0% in the 1st quarter. JPMorgan Chase & Co. now owns 16,362 shares of the specialty chemicals company’s stock worth $208,000 after purchasing an additional 2,256 shares in the last quarter. MetLife Investment Management LLC increased its holdings in Aemetis by 57.0% in the 1st quarter. MetLife Investment Management LLC now owns 15,153 shares of the specialty chemicals company’s stock worth $192,000 after purchasing an additional 5,501 shares in the last quarter. Citigroup Inc. increased its holdings in Aemetis by 15.0% in the 1st quarter. Citigroup Inc. now owns 50,504 shares of the specialty chemicals company’s stock worth $640,000 after purchasing an additional 6,603 shares in the last quarter. Finally, Raymond James & Associates increased its holdings in Aemetis by 64.4% in the 1st quarter. Raymond James & Associates now owns 18,120 shares of the specialty chemicals company’s stock worth $230,000 after purchasing an additional 7,097 shares in the last quarter. Institutional investors and hedge funds own 52.75% of the company’s stock.

About Aemetis

(Get Rating)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.

Read More

Earnings History for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.